Why Intuitive Machines Is Taking Off While Broader Market Sinks — Negative
LUNR MarketBeat — November 19, 2025Intuitive Machines NASDAQ: LUNR is up 7.8% on a day when the broader market continues to move lower. The lunar exploration company has had no new launches, nor were there any developments in its financial results that would trigger such a move.
BIAF Stock Dips After Q3 Earnings Reflect Lower Sales and Wider Loss — Negative
BIAF Zacks Investment Research — November 19, 2025bioAffinity's third-quarter 2025 performance shows lower sales and a wider loss as it pivots to focus on CyPath Lung and expands VA system adoption.
Precipio Stock Up Following Solid Q3 Earnings and Improved Cash Flow — Positive
PRPO Zacks Investment Research — November 19, 2025PRPO reports strong third-quarter 2025 results with higher revenue, positive cash flow and improved margins in core divisions.
Berkshire Hathaway's Net Margin Fluctuates: Can it Stabilize? — Positive
BRK-A BRK-B Zacks Investment Research — November 19, 2025BRK.B's wide-ranging operations offer stability but drive margin swings as insurance, investments and major segments face shifting conditions.
Asbury Automotive Group: Attractively Valued Amid A Challenging Economic Backdrop — Positive
ABG Seeking Alpha — November 19, 2025Asbury Automotive Group continues to enjoy a healthy mix of organic and inorganic growth, acquiring Herb Chambers in Q3 2025. This resulted in a 13% Y/Y rise in Q3 2025 adjusted EPS, although analysts are more cautious heading into Q4 2025 earnings. Stronger GDP growth, $50 million in quarterly share repurchases, and lower Fed rates lay a strong foundation to continued EPS growth in 2026, in contrast to analyst expectations.
AIG Withdrew Executive Hire After Inquiry Into Alleged Inappropriate Workplace Relationship — Negative
AIG WSJ — November 19, 2025John Neal's previous employer, Lloyd's of London, reopened an investigation into his conduct.
Adobe, Qualcomm partner with Humain on generative AI for Middle East — Positive
ADBE QCOM Reuters — November 19, 2025Adobe and Qualcomm said on Wednesday they are partnering with Humain, the artificial intelligence firm backed by Saudi Arabia's sovereign wealth fund, to help the AI company develop tools for generating content in Arabic and for the broader Middle East.
Target Details Consumer Strain and Unveils Its Chatbot Plans — Negative
TGT PYMNTS — November 19, 2025Target's third-quarter 2025 earnings results suggest that consumers are under growing pressure, a dynamic that could shape holiday spending patterns across the retail sector. While inventory is tight heading into the fourth quarter, management said shoppers remain cautious and selective, creating an uncertain backdrop for the most important shopping period of the year.
BOOT's Omnichannel Strength: Is AI the New Profit Driver? — Positive
BOOT Zacks Investment Research — November 19, 2025Boot Barn's Q2 digital momentum accelerates as AI-powered upgrades and new brand sites fuel 14% e-commerce same-store sales growth.
DAL vs. AAL: Which Airline Stock Looks More Promising Now? — Positive
AAL DAL Zacks Investment Research — November 19, 2025DAL's strong guidance, dividend hikes and steadier balance sheet help it outshine AAL as both carriers face higher labor costs and shifting demand.
RGTI Stock Plunges 41% in a Month: Should Investors Hold or Fold? — Neutral
RGTI Zacks Investment Research — November 19, 2025Rigetti's 41% dip weighs on sentiment, but steady contracts, partnerships and hardware progress keep investors watching the long-term path.
Is Innodata Becoming a Critical Data Partner for Big Tech AI? — Positive
INOD Zacks Investment Research — November 19, 2025INOD posts record Q3 revenue as it cements its role in Big Tech's AI pipelines, landing five new major AI partnerships.
Why Is AGNC Investment (AGNC) Up 0.6% Since Last Earnings Report? — Positive
AGNC Zacks Investment Research — November 19, 2025AGNC Investment (AGNC) reported earnings 30 days ago. What's next for the stock?
RLI Corp. (RLI) Up 4.2% Since Last Earnings Report: Can It Continue? — Positive
RLI Zacks Investment Research — November 19, 2025RLI Corp. (RLI) reported earnings 30 days ago. What's next for the stock?
Why Is Steel Dynamics (STLD) Up 0.5% Since Last Earnings Report? — Positive
STLD Zacks Investment Research — November 19, 2025Steel Dynamics (STLD) reported earnings 30 days ago. What's next for the stock?
W.R. Berkley (WRB) Up 3.3% Since Last Earnings Report: Can It Continue? — Positive
WRB Zacks Investment Research — November 19, 2025W.R. Berkley (WRB) reported earnings 30 days ago. What's next for the stock?
Why Is Cleveland-Cliffs (CLF) Down 16.4% Since Last Earnings Report? — Negative
CLF Zacks Investment Research — November 19, 2025Cleveland-Cliffs (CLF) reported earnings 30 days ago. What's next for the stock?
Why Is Zions (ZION) Down 6.4% Since Last Earnings Report? — Negative
ZION Zacks Investment Research — November 19, 2025Zions (ZION) reported earnings 30 days ago. What's next for the stock?
Novartis announces plans to build flagship manufacturing hub in North Carolina — Neutral
NVS GlobeNewsWire — November 19, 2025Basel, November 19, 2025 – Novartis, a leading global innovative medicines company, today announced plans to expand its operations in North Carolina, creating a new flagship manufacturing hub with end-to-end manufacturing capabilities. The strategic investment is a major step to ensure all key Novartis medicines for US patients are manufactured in the US and delivered to patients across the country at scale. This announcement is part of Novartis' $23 billion investment in US-based infrastructure over the next five years, designed to increase manufacturing capacity and enable 100% of the company's key medicines to be produced end-to-end in the US. As …
Novartis announces plans to build flagship manufacturing hub in North Carolina — Neutral
NVS GlobeNewsWire — November 19, 2025East Hanover, November 19, 2025 – Novartis, a leading global innovative medicines company, today announced plans to expand its operations in North Carolina, creating a new flagship manufacturing hub with end-to-end manufacturing capabilities. The strategic investment is a major step to ensure all key Novartis medicines for US patients are manufactured in the US and delivered to patients across the country at scale.